The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
FAK in cancer: mechanistic findings and clinical applications
Open accessAbstract
Focal adhesion kinase (FAK) is a cytoplasmic protein tyrosine kinase that is overexpressed and activated in several advanced-stage solid cancers. FAK promotes tumour progression and metastasis through effects on cancer cells, as well as stromal cells of the tumour microenvironment. The kinase-dependent and kinase-independent functions of FAK control cell movement, invasion, survival, gene expression and cancer stem cell self-renewal. Small molecule FAK inhibitors decrease tumour growth and metastasis in several preclinical models and have initial clinical activity in patients with limited adverse events. In this Review, we discuss FAK signalling effects on both tumour and stromal cell biology that provide rationale and support for future therapeutic opportunities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, multiple previous studies have implicated FAK activation in the development of resistance against various chemotherapy agents through its regulation of the tumor microenvironment.[ 11, 15, 44 ]”
From Focal Adhesion Kinase (FAK) Inhibition Synergizes with KRAS G12C Inhibitors in Treating Cancer through the Regulation of the FAK–YAP Signaling (2021) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
The protein kinase complement of the human genome
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,927
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Focal adhesion kinase: in command and control of cell motility
Mitra, S. K., Hanson, D. A., & Schlaepfer, D. D. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1549 · Cited by 2,657
Self-citationFocal adhesion kinase: the first ten years
Parsons, J. T. (2003) · Journal of Cell Science · doi:10.1242/jcs.00373 · Cited by 1,389
The role of focal-adhesion kinase in cancer — a new therapeutic opportunity
McLean, G. W., Carragher, N. O., Avizienyte, E., EVANS, J., Brunton, V. G., & Frame, M. C. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1647 · Cited by 1,049
E-cadherin–integrin crosstalk in cancer invasion and metastasis
Canel, M., Serrels, A., Frame, M. C., & Brunton, V. G. (2013) · Journal of Cell Science · doi:10.1242/jcs.100115 · Cited by 651
Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions
Schaller, M. D. (2010) · Journal of Cell Science · doi:10.1242/jcs.045112 · Cited by 613
Signal transduction by focal adhesion kinase in cancer
Zhao, J., & Guan, J. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9165-4 · Cited by 608
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,000
Talia, M., Cesario, E., Cirillo, F., Scordamaglia, D., Dio, M. D., Zicarelli, A., Mondino, A. A., Occhiuzzi, M. A., Francesco, E. M. D., Belfiore, A., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05413-2 · Cited by 28
Wieczorek, K., Wiktorska, M., Sacewicz‐Hofman, I., Boncela, J., Lewiñski, A., Kowalska, M. A., & Niewiarowska, J. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.07.035 · Cited by 28
Satow, R., Inagaki, S., Kato, C., Shimozawa, M., & Fukami, K. (2017) · Cancer Science · doi:10.1111/cas.13419 · Cited by 28
Snake Venom Disintegrins: An Overview of their Interaction with Integrins
César, P. H. S., Braga, M. A., Trento, M. V. C., Menaldo, D. L., & Marcussi, S. (2018) · Current Drug Targets · doi:10.2174/1389450119666181022154737 · Cited by 28
TRAF2 Cooperates with Focal Adhesion Signaling to Regulate Cancer Cell Susceptibility to Anoikis
da Silva, S. D., Xu, B., Maschietto, M. C., Marchi, F. A., Alkailani, M. I., Bijian, K., Xiao, D., & Alaoui‐Jamali, M. A. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-1261 · Cited by 28
Inhibition of FAK Signaling Elicits Lamin A/C-Associated Nuclear Deformity and Cellular Senescence
Chuang, H.-H., Wang, P., Niu, S., Zhen, Y., Huang, M., Hsiao, M., & Yang, C. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00022 · Cited by 29
Fluid flow-induced activation of subcellular AMPK and its interaction with FAK and Src
Guo, Y., Steele, H. E., Li, B., & Na, S. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.108208 · Cited by 28
The Membrane Protein Sortilin Can Be Targeted to Inhibit Pancreatic Cancer Cell Invasion
Gao, F., Griffin, N., Faulkner, S., Li, X., King, S. J., Jobling, P., Denham, J. W., Jiang, C. C., & Hondermarck, H. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.05.018 · Cited by 29
Vitamin C: A stem cell promoter in cancer metastasis and immunotherapy
Fu, J., Wu, Z., Liu, J., & Wu, T. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110588 · Cited by 28
Potent molecular-targeted therapies for advanced esophageal squamous cell carcinoma
Ooki, A., Osumi, H., Chìn, K., Watanabe, M., & Yamaguchi, K. (2023) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359221138377 · Cited by 28
Dual roles of FAK in tumor angiogenesis: A review focused on pericyte FAK
Zhang, J., Li, W., Wang, W., Chen, Q., Xu, Z., Deng, M., Zhou, L., & He, G. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175694 · Cited by 28
Millar, M. W., Corson, N., & Xu, L. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00008 · Cited by 28
Chen, Y., Lu, M., El‐Shazly, M., Lai, K.-H., Wu, T., Hsu, Y., Lee, Y.-L., & Liu, Y. (2018) · Marine Drugs · doi:10.3390/md16060212 · Cited by 28
EpCAM associates with integrin and regulates cell adhesion in cancer cells
Yang, J. A., Isaji, T., Zhang, G., Qi, F., Duan, C., Fukuda, T., & Gu, J. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.11.152 · Cited by 28
Wei, W., Feng, Z., Liu, Z., Li, X., He, H., Ran, K., Shi, Y., Zhu, Y., Ye, T., Gao, C., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113978 · Cited by 27
Roy-Luzarraga, M., Reynolds, L. E., de Luxán‐Delgado, B., Maiques, Ó., Wisniewski, L., Newport, E., Rajeeve, V., Drake, R. J. G., Gómez-Escudero, J., Richards, F. M., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-20-3807 · Cited by 28
P130cas-FAK interaction is essential for YAP-mediated radioresistance of non-small cell lung cancer
Li, J., Zhang, X., Hou, Z., Cai, S., Guo, Y., Sun, L., Li, A., Li, Q., Wang, E., & Miao, Y. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05224-7 · Cited by 28
Alexopoulou, A. N., Lees, D. M., Bodrug, N., Lechertier, T., Fernandez, I., D’Amico, G., Dukinfield, M., Batista, S., Tavora, B., Serrels, B., et al. (2017) · The Journal of Pathology · doi:10.1002/path.4911 · Cited by 27
Ogasawara, N., Kudo, T., Sato, M., Kawasaki, Y., Yonezawa, S., Takahashi, S., Miyagi, Y., Natori, Y., & Sugiyama, A. (2018) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b17-00990 · Cited by 27
Androgen Receptor-CaMKK2 Axis in Prostate Cancer and Bone Microenvironment
Dadwal, U. C., Chang, E. S., & Sankar, U. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00335 · Cited by 27
Li, H., Hu, S., Pang, Y., Li, M., Chen, L., Liu, F., Liu, M., Wang, Z., & Cheng, X. (2018) · Europe PMC (PubMed Central) · Cited by 27
CircRPAP2 regulates the alternative splicing of PTK2 by binding to SRSF1 in breast cancer
Yu, Y., & Fang, L. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-00965-y · Cited by 27
Jeong, K. (2018) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v10.i10.290 · Cited by 27
KRAS mutations in advanced non-small cell lung cancer: From biology to novel therapeutic strategies
Liguori, L., Salomone, F., Viggiano, A., Sabbatino, F., Pepe, S., Formisano, L., Bianco, R., & Servetto, A. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104554 · Cited by 27
Focal adhesions are foci for tyrosine-based signal transduction via GIV/Girdin and G proteins
López-Sánchez, I., Kalogriopoulos, N. A., Lo, I., Kabir, F., Midde, K., Wang, H., & Ghosh, P. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-07-0496 · Cited by 26
Leyme, A., Marivin, A., & Garcia‐Marcos, M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.691550 · Cited by 26
Molist, C., Navarro, N., Giralt, I., Zarzosa, P., Gallo-Oller, G., Pons, G., Magdaleno, A., Moreno, L., Guillén, G., Hladun, R., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.02.035 · Cited by 26
FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitro
Mohamed, A. A., Thomsen, A. R., Follo, M., Zamboglou, C., Bronsert, P., Mostafa, H., Amen, A., Mekawy, M., Grosu, A., & Brunner, T. B. (2020) · Strahlentherapie und Onkologie · doi:10.1007/s00066-020-01666-0 · Cited by 26
RAGE Up-Regulation Differently Affects Cell Proliferation and Migration in Pancreatic Cancer Cells
Swami, P., Thiyagarajan, S., Vidger, A. J., Indurthi, V. S. K., Vetter, S. W., & Leclerc, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207723 · Cited by 26
Tumour suppression through modulation of neprilysin signaling: A comprehensive review
Sankhe, R., Pai, K. S. R., & Kishore, A. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173727 · Cited by 26
Emerging technologies provide insights on cancer extracellular matrix biology and therapeutics
Cruz‐Acuña, R., Vunjak‐Novakovic, G., Burdick, J. A., & Rustgi, A. K. (2021) · iScience · doi:10.1016/j.isci.2021.102475 · Cited by 26
Lu, D., Wang, Y., Zhang, T., Wang, F., Li, K., Zhou, S., Zhu, H., Yang, Z., & Liu, Z. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00924-2 · Cited by 26
Zhou, Y., Bai, L., Li, T. X., Yang, L., Zhang, H., Zhang, Y., Hao, J., Gu, Y., & Liu, Y. (2021) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2021.111550 · Cited by 26
Kwon, Y. M., Park, S.-J., Nguyen, B. T., Kim, M. J., Oh, S., Lee, H., Park, N., Kim, H. S., Kang, M., Min, B. S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-96635-7 · Cited by 26
Chen, J., Wang, Y., Zhao, D., Zhang, L., Zhang, W., Fan, J., Li, J., & Zhan, Q. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.07.011 · Cited by 26
Fan, C., Wu, Z., Cooper, D. M. L., Magnus, A., Harrison, K. D., Eames, B. F., Chibbar, R., Groot, G., Huang, J., Genth, H., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105593 · Cited by 26
PYK2 senses calcium through a disordered dimerization and calmodulin-binding element
Momin, A. A., Mendes, T., Barthe, P., Faure, C., Hong, S., Yu, P., Kadaré, G., Jaremko, M., Girault, J., Jaremko, Ł., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03760-8 · Cited by 26
FAK Drives Resistance to Therapy in HPV-Negative Head and Neck Cancer in a p53-Dependent Manner
Pifer, P. M., Yang, L., Kumar, M., Xie, T., Frederick, M. J., Hefner, A. J., Beadle, B. M., Molkentine, D. P., Molkentine, J. M., Dhawan, A., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-0964 · Cited by 27
Gambogic Acid and Its Role in Chronic Diseases
Pandey, M. K., Karelia, D. N., & Amin, S. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-41334-1_15 · Cited by 26
Epigenetic regulation of RTK signaling
Spangle, J. M., & Roberts, T. M. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1546-0 · Cited by 26
Hasan, R., & Zhou, G.-L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112653 · Cited by 26
Lorusso, G., Rüegg, C., & Kuonen, F. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01231 · Cited by 28
Prosdocimi, E., Carpanese, V., Todesca, L. M., Varanita, T., Bachmann, M., Festa, M., Bonesso, D., Pérez-Verdaguer, M., Carrer, A., Velle, A., et al. (2024) · Science Advances · doi:10.1126/sciadv.adn9361 · Cited by 25
Mechanical regulation of metabolism, epigenetics, and their interplay
Nam, H., Yu, G., Ahn, S. I., & Nam, S. (2026) · npj Biomedical Innovations. · doi:10.1038/s44385-025-00059-1 · Cited by 25
Farsky, S. H. P., Drewes, C. C., Fiel, L. A., Bexiga, C. G., Asbahr, A. C. C., Uchiyama, M. K., Cogliati, B., Araki, K., Guterres, S. S., & Pohlmann, A. R. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s101543 · Cited by 25
Toutounchian, J. J., Pagadala, J., Miller, D. D., Baudry, J. Y., Park, F., Chaum, E., & Yates, C. R. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.105031 · Cited by 25
Lin, H., Zhang, X., Liao, L., Yu, T., Li, J., Pan, H., Liu, L., Kong, H., Sun, L., Yan, M., et al. (2018) · Journal of Cancer · doi:10.7150/jca.25872 · Cited by 25
Erhart, F., Hackl, M., Hahne, H., Buchroithner, J., Meng, C., Klingenbrunner, S., Reitermaier, R., Fischhuber, K., Skalicky, S., Berger, W., et al. (2020) · npj Vaccines · doi:10.1038/s41541-019-0149-x · Cited by 25
Ying, H., Feng, L., Ding, R., Wang, W., & Hong, W. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112144 · Cited by 25
Stromal Protein-Mediated Immune Regulation in Digestive Cancers
Gamradt, P., de la Fouchardière, C., & Hennino, A. (2021) · Cancers · doi:10.3390/cancers13010146 · Cited by 27
Gilardi, M., Bersini, S., Valtorta, S., Proietto, M., Crippa, M., Boussommier-Calleja, A., Labelle, M., Moresco, R. M., Vanoni, M., Kamm, R. D., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120975 · Cited by 26
Zhang, L., Yao, L., Zhou, W., Tian, J., Ruan, B., Lu, Z., Deng, Y., Li, Q., Zeng, Z. R., Yang, D., et al. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.07.025 · Cited by 25
Fang, D., Shi, X., Jia, X., Yang, C., Wang, L., Du, B., Lu, T., Shan, L., & Gao, Y. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101400 · Cited by 25
Meisaprow, P., Aksorn, N., Vinayanuwattikun, C., Pithi Chanvorachote, B., & Sukprasansap, M. (2021) · Molecules · doi:10.3390/molecules26247659 · Cited by 25
FAK/IL-8 axis promotes the proliferation and migration of gastric cancer cells
Ma, Y., Fu, Y., Fan, X., Ji, Q., Duan, X., Wang, Y., Zhang, Y., Wang, Z., & Hao, H. (2023) · Gastric Cancer · doi:10.1007/s10120-023-01384-3 · Cited by 25
Prognostic Value of Focal Adhesion Kinase (FAK) in Human Solid Carcinomas: A Meta-Analysis
Zeng, X., Li, N., Ma, L., Tseng, Y., Zhao, N., & Chen, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162666 · Cited by 25
Foy, M., Anezo, O., Saule, S., & Planque, N. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.03.012 · Cited by 25
Dysregulation of Blimp1 transcriptional repressor unleashes p130Cas/ErbB2 breast cancer invasion
Sciortino, M., Leal, M. D. P. C., Orso, F., Grassi, E., Costamagna, A., Provero, P., Tam, W., Turco, E., Defilippi, P., Taverna, D., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01332-z · Cited by 25
Grauzam, S. E., Brock, A. M., Holmes, C. O., Tiedeken, J. A., Boniface, S. G., Pierson, B. N., Patterson, D. G., Coaxum, S. D., Neskey, D. M., & Rosenzweig, S. A. (2018) · Oncotarget · doi:10.18632/oncotarget.25347 · Cited by 25
Lin, T., Tseng, A.-J., Qiu, W.-L., Chao, C., & Lu, M. (2019) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2019.01.078 · Cited by 25
Zhou, W., Chen, H., Ruan, Y., Zeng, X., & Liu, F. (2020) · Journal of Investigative Surgery · doi:10.1080/08941939.2019.1705443 · Cited by 25
Bastin, J., Sroussi, M., Nemazanyy, I., Laurent-Puig, P., Mouillet-Richard, S., & Djouadi, F. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04341-x · Cited by 24
Steinestel, K., Trautmann, M., Jansen, E.-P., Dirksen, U., Rehkämper, J., Mikesch, J., Gerke, J. S., Orth, M. F., Sannino, G., Arteaga, M. F., et al. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12610 · Cited by 24
New Insights on Fak and Fak Inhibitors
Brullo, C., & Tasso, B. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666201103162239 · Cited by 24
Groendyke, B. J., Nabet, B., Mohardt, M. L., Zhang, H., Peng, K., Koide, E., Coffey, C. R., Che, J., Scott, D. A., Bass, A. J., et al. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00338 · Cited by 24
Das, V., Kaishap, P. P., Duarah, G., Chikkaputtaiah, C., Boruah, H. P. D., & Pal, M. (2021) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-021-02063-9 · Cited by 24
Phosphorylated paxillin and phosphorylated FAK constitute subregions within focal adhesions
Bachmann, M., Skripka, A., Weißenbruch, K., Wehrle‐Haller, B., & Bastmeyer, M. (2022) · Journal of Cell Science · doi:10.1242/jcs.258764 · Cited by 24
Ng, E. F. Y., Kaida, A., Nojima, H., & Miura, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-15737-y · Cited by 24
Gutierrez, N. M. C., Pujol‐Solé, N., Arifi, Q., Coll, J., Clainche, T. L., & Broekgaarden, M. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10064-0 · Cited by 25
Haake, S. M., Li, J., Bai, Y., Kinose, F., Fang, B., Welsh, E. A., Zent, R., Dhillon, J., Pow‐Sang, J. M., Chen, Y. A., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1673 · Cited by 24
Kishi, T., Mayanagi, T., Iwabuchi, S., Akasaka, T., & Sobue, K. (2016) · Oncotarget · doi:10.18632/oncotarget.12350 · Cited by 24
Molecular and cellular impact of Psoriasin (S100A7) on the healing of human wounds
Rangaraj, A., Ye, L., Sanders, A. J., Price, P., Harding, K. G., & Jiang, W. G. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4275 · Cited by 24
Weber, A., Dam, S., Saul, V. V., Kuznetsova, I., Müller, C., Fritz‐Wolf, K., Becker, K., Linne, U., Gu, H., Stokes, M. P., et al. (2019) · Journal of Virology · doi:10.1128/jvi.00528-19 · Cited by 24
Lu, J., Li, X., Tu, K., Guan, Y., Fung, K., & Liu, F. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s208683 · Cited by 24
NEDD9 promotes invasion and migration of colorectal cancer cell line HCT116 via JNK/EMT
Meng, H., Wu, J., Huang, Q. Y., Yang, X., Yang, K., Qiu, Y., Ren, J., Shen, R., & Qi, H. (2019) · Oncology Letters · doi:10.3892/ol.2019.10756 · Cited by 24
Solanki, H. S., Raja, R., Zhavoronkov, A. A., Ozerov, I. V., Artemov, A. V., Advani, J., Radhakrishnan, A., Babu, N., Puttamallesh, V. N., Syed, N., et al. (2018) · Oncoscience · doi:10.18632/oncoscience.395 · Cited by 24
Critical role of lipid membranes in polarization and migration of cells: a biophysical view
Sackmann, E., & Tanaka, M. (2021) · Biophysical Reviews · doi:10.1007/s12551-021-00781-1 · Cited by 26
Electrophilic Natural Products as Drug Discovery Tools
Gehrtz, P., & London, N. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.03.008 · Cited by 25
The emerging promise of tumour mechanobiology in cancer treatment
Papavassiliou, K. A., Basdra, E. K., & Papavassiliou, A. G. (2023) · European Journal of Cancer · doi:10.1016/j.ejca.2023.112938 · Cited by 23
Zeng, Y., Li, Q., Hu, Y., Hu, H., Xu, J., Guo, M., Zhang, W., Lou, X., Wang, Y., Gao, H., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216769 · Cited by 26
Takai, R., Uehara, O., Harada, F., Utsunomiya, M., Chujo, T., Yoshida, K., Sato, J., Nishimura, M., Chiba, I., & Abiko, Y. (2015) · Journal of Periodontal Research · doi:10.1111/jre.12330 · Cited by 23
Feng, H., Zhong, L., Yang, X., Wan, Q., Pei, X., & Wang, J. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00294-y · Cited by 24
Zhang, Y., Xu, B., Shi, J., Li, J., Lu, X., Xu, L., Yang, H. L., Hamad, N., Wang, C., Napier, D. L., et al. (2020) · Cellular Oncology · doi:10.1007/s13402-020-00537-1 · Cited by 23
Tian, H., Chou, F.-J., Tian, J., Zhang, Y., You, B., Huang, C., Yeh, S., Niu, Y., & Chang, C. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01760-2 · Cited by 23
Xie, H., Jiao, Y., Zhou, X., Liao, X., Chen, J., Chen, H., Chen, L., Yu, S., Deng, Q., Sun, L., et al. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.113003 · Cited by 23
Huang, T., Li, Y.-Q.-X., Zhou, M., Hu, R.-H., Zou, G.-L., Li, J.-C., Feng, S. Y., Liu, Y., Xin, C.-Q., & Zhao, X. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i1.123 · Cited by 23
Alves, G. F., Aimaretti, E., Einaudi, G., Mastrocola, R., Oliveira, J. G., Collotta, D., Porchietto, E., Aragno, M., Cifani, C., Sordi, R., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.837180 · Cited by 24
Rajesh, C., Sagar, S., Ashokkumar, R., Chemparathy, D. T., Peng, X. L., Yeh, J. J., Hollingsworth, M. A., & Radhakrishnan, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105459 · Cited by 23
Identification of hub genes involved in cisplatin resistance in head and neck cancer
Chaudhary, R. K., Khanal, P., Mateti, U. V., Shastry, C. S., & Shetty, J. (2023) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-023-00468-y · Cited by 23
Long, Z., Zuo, Y., Li, R., Le, Y., Dong, Y., & Yan, L. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106792 · Cited by 23
Suttithumsatid, W., Sukketsiri, W., & Panichayupakaranant, P. (2023) · Toxicology in Vitro · doi:10.1016/j.tiv.2023.105667 · Cited by 23
Zhang, B., Zhang, Z., Gao, J., Lu, S., Pang, R., Li, D., Huang, X., Qin, N., Liu, L., & Wang, Z. (2024) · iScience · doi:10.1016/j.isci.2024.111536 · Cited by 24
Role of Acid Sphingomyelinase-Induced Signaling in Melanoma Cells for Hematogenous Tumor Metastasis
Carpinteiro, A., Beckmann, N., Seitz, A. P., Hessler, G., Wilker, B., Soddemann, M., Helfrich, I., Edelmann, B., Gulbins, E., & Becker, K. A. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000438604 · Cited by 23
A20 inhibits the motility of HCC cells induced by TNF-α
Wang, X., Ma, C., Zong, Z., Xiao, Y., Li, N., Guo, C. H., Zhang, L., & Shi, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.7521 · Cited by 23
Kinase inhibitors as potential agents in the treatment of multiple myeloma
Abramson, H. N. (2016) · Oncotarget · doi:10.18632/oncotarget.10745 · Cited by 23
Zhou, Q. S., Guo, X., & Choksi, R. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.240507 · Cited by 23
Liu, H., Wu, B., Yang, G., Huang, J., Song, S., Wang, C., Yao, J., Liu, K., Li, Y., Li, Y., et al. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.09.041 · Cited by 23
Li, Y., Zhang, Y., Zhang, J., Zhan, Z., & Mao, W. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116913 · Cited by 22
FAK Promotes Early Osteoprogenitor Cell Proliferation by Enhancing mTORC1 Signaling
Qi, S., Sun, X., Choi, H. K., Yao, J., Wang, L., Wu, G., He, Y., Pan, J., Guan, J., & Liu, F. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4029 · Cited by 22
Wang, X., Mak, P. Y., Mu, H., Tao, W., Rao, A. U. K., Ravikumar, V., Ruvolo, V. R., Pachter, J. A., Weaver, D. T., Andreeff, M., et al. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0841 · Cited by 22
Metadata
- Authors
- Sulzmaier, F. J., Jean, C., & Schlaepfer, D. D.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Schlaepfer, David D.
- Venue
- Nature Reviews Cancer
- Published
- 2014-08-07
- Volume
- 14
- Issue
- 9
- Pages
- 598-610
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC4365862
- OpenAlex
- W2044423100
- Cited by
- 1,381
- References
- 142
- Citations by year
- 2026: 92 · 2025: 85 · 2024: 131 · 2023: 111 · 2022: 147 · 2021: 154 · 2020: 144 · 2019: 122 · 2018: 105 · 2017: 128 · 2016: 91 · 2015: 63 · 2014: 6
- FWCI
- 12.73
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- American Heart Association
- Verastem Oncology
- National Institutes of Health
- National Cancer Institute (R01CA102310, CA102310, R01CA180769, CA180769, T32CA121938)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- focal adhesion kinase, FAK inhibitors, tumor microenvironment, tumor stromal cells, metastasis, tumor progression, cancer stem cells, cell invasion, cell migration, small molecule inhibitors, clinical development
- MeSH terms
- Animals, Humans, Neoplasm Invasiveness, Neoplasms, Signal Transduction, Stromal Cells, Protein Kinase Inhibitors, Focal Adhesion Kinase 1, Small Molecule Libraries, Molecular Targeted Therapy, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review